Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05784233 · ClinicalTrials.gov registry record · NA

Relevance and Salience During Attention Task

A NA study, sponsored by Lehigh University.

Completed
Registry status
NA
Development phase
117
Enrollment target

NCT05784233: Completed NA study, sponsored by Lehigh University.

NCT05784233 is a NA study that has completed, run by Lehigh University. The registered enrollment target is 117 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05784233, a NA study, has completed, sponsored by Lehigh University.

COMPLETED
Registry status
NA
Development phase
117 participants
Enrollment target

Study Summary

In this line of research, the researchers are examining the influence of relevance of a salient item on task performance, depending on overall task set.

Primary Outcome

Speed to respond correctly to the target- after participant finds the target shape on a computer screen, they press a button to indicate what shape they see

Interventions

  • BEHAVIORAL Relevance (Likelihood Salient Item is Target)

Trial Details

FieldValue
Enrollment Target 117 participants
Start Date 2022-09-15
Est. Completion 2022-10-28
Phase NA
Lehigh University

12 total trials

What the finished NCT05784233 record still lists

NCT05784233 is an interventional study that assigns participants to a tested intervention. The registered 117 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 1 intervention - of which Relevance (Likelihood Salient Item is Target) is the first listed.

NCT05784233 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05784233 about?

NCT05784233 is a clinical study titled "Relevance and Salience During Attention Task". In this line of research, the researchers are examining the influence of relevance of a salient item on task performance, depending on overall task set.

What is the current status of trial NCT05784233?

This trial is currently completed. It is a NA study. The enrollment target is 117 participants. The study started on 2022-09-15. Estimated completion is 2022-10-28.

What interventions are being tested in trial NCT05784233?

The interventions under investigation include: Relevance (Likelihood Salient Item is Target) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05784233?

This trial is sponsored by Lehigh University, which has 12 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05784233's enrollment target sits among peer trials

117 807th of 2000 higher than 1,193 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03539822 · 117 participants · Phase 1

    Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies

  • NCT03786692 · 117 participants · Phase 2

    Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC

  • NCT04479696 · 117 participants · NA

    Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors

  • NCT04940585 · 117 participants · NA

    ROSE in Sunset Park

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05784233, the US trial registry maintained by the National Library of Medicine. NCT05784233 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.